BrightSpring Health Services, Inc.

BTSG Healthcare Health Information Services

BrightSpring Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $12.9 billion, up 28.2% from fiscal 2024.

Revenue
+26.4%
EPS
+77.8%
Free cash flow
+97.7%
Total debt
−13.2%

Quarter to September 2026, against a year earlier

67.27 1.41 +2.14%
Market cap
$13.1B
P/E
33.0×
Fwd P/E
41.2×
Dividend yield
—
F-score
7/9
Altman Z
3.35
Beneish M
−2.64
Dividend safety
n/a

BrightSpring Health Services, Inc. (BTSG) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 6 added · 7 removed · 34 modified
P2I1A: no material changes, the filing says
Share dilution
8-K Oct 30, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026
8-K Jul 31, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 11, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
8-K Jun 3, 2026 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K May 21, 2026 5.07 Submission of matters to a vote of security holders
10-Q Mar 31, 2026
8-K May 1, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 30, 2026 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 2, 2026 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 1 added · 57 modified
1A: 4 added · 10 removed · 126 modified
7: 21 added · 33 removed · 86 modified
8-K Feb 27, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 28, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Oct 20, 2025 1.01 Entry into a material definitive agreement; 9.01 Financial statements and exhibits
8-K Oct 20, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Aug 1, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K May 2, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Mar 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Nov 1, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 2, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 2, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 29, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.